Overactive bladder symptom bother and health-related quality of life in patients with systemic lupus erythematosus and primary Sjögren syndrome

Abstract

Objective

The objective of this paper is to assess overactive bladder (OAB) symptom bother (SB) and health-related quality of life (HRQL) among patients with systemic lupus erythematosus (SLE) and primary Sjögren syndrome (pSS).

Methods

We recruited adult SLE and pSS patients and two groups of age- and sex-matched controls. We applied the OAB questionnaire-short form (OABq-SF) to all participants to assess SB and HRQL and collected clinical information relevant for OAB. We compared the OABq-SF scores for SB and HRQL between patients and controls using univariate and multivariate linear regression analysis.

Results

We recruited 95 rheumatic patients (68 SLE, 27 pSS) and 231 controls. Compared to controls SLE patients showed higher OABq-SF SB scores (22.6 ± 20.4 vs 14.7 ± 17.0, p = 0.004) and lower HRQL scores (89.8 ± 15.8 vs 93.8 ± 11.4, p = 0.044). On multivariate analysis SLE was significantly associated with a higher SB score (ß-coefficient 7.13, p = 0.008) and tended to be associated with worse HRQL values (ß-coefficient –3.53, p = 0.055). Patients with pSS had numerically higher mean SB scores (22.8 ± 22.5 vs 16.2 ± 18.0, respectively, p = 0.107) and lower HRQL scores (91.0 ± 10.7 vs 93.2 ± 11.6, respectively, p = 0.369), although these differences were not statistically significant. Diagnosis of pSS was not significantly associated with SB or HRQL scores on univariate or multivariate analysis.

Conclusions

Patients with SLE have significantly worse OAB-SB and poorer HRQL compared to controls. A similar trend was seen for pSS patients, especially for SB. These findings suggest that clinically subtle OAB symptoms may be present in rheumatic patients for whom, later on, bladder pain syndrome may occur.

Keywords

Interstitial cystitis overactive bladder painful bladder syndrome Sjögren syndrome surveys and questionnaires systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Belknap

Blalock

Erickson

. The challenges of interstitial cystitis: Current status and future prospects. Drugs 2015; 75: 2057–2063.

Lai

Vetter

Jain

Gereau

4th Andriole

. The overlap and distinction of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder: A questionnaire based analysis. J Urol 2014; 192: 1679–1685.

Hoffman

. Central and peripheral pain generators in women with chronic pelvic pain: Patient centered assessment and treatment. Curr Rheumatol Rev 2015; 11: 146–166.

van de Merwe

. Interstitial cystitis and systemic autoimmune diseases. Nat Clin Pract Urol 2007; 4: 484–491.

Haarala

Alanen

Hietarinta

Kiilholma

. Lower urinary tract symptoms in patients with Sjögren’s syndrome and systemic lupus erythematosus. Int Urogynecol J Pelvic Floor Dysfunct 2000; 11: 84–86.

Lee

Dong

Chen

, et al. Multifactorial causes of irritating bladder symptoms in patients with Sjögren’s syndrome. Neurourol Urodyn 2011; 30: 97–101.

Ueda

Tomoe

Takahashi

, et al. Interstitial cystitis associated with primary Sjögren’s syndrome successfully treated with a combination of tacrolimus and corticosteroid: A case report and literature review. Mod Rheumatol 2016; 26: 445–449.

Koh

Lee

Jung

, et al. Lupus cystitis in Korean patients with systemic lupus erythematosus: Risk factors and clinical outcomes. Lupus 2015; 24: 1300–1307.

Mykoniatis

Katafigiotis

Sfoungaristos

Yutkin

. Immunotherapy options for painful bladder syndrome: What’s the potential? Expert Opin Biol Ther 2017; 17: 1471–1480.

10.

Crescenze

Tucky

Moore

Shoskes

. Efficacy, side effects, and monitoring of oral cyclosporine in interstitial cystitis-bladder pain syndrome. Urology 2017; 107: 49–54.

11.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.

12.

Vitali

Bombardieri

Jonsson

, et al. Classification criteria for Sjögren’s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554–558.

13.

Acquadro

Kopp

Coyne

, et al. Translating overactive bladder questionnaires in 14 languages. Urology 2006; 67: 536–540.

14.

Coyne

Thompson

Lai

Sexton

. An overactive bladder symptom and health-related quality of life short-form: Validation of the OAB-q SF. Neurourol Urodyn 2015; 34: 255–263.

15.

Palma

Raimondi

Souto

Fozzatti

Palma

Riccetto

. Correlation between age and overactive bladder symptoms in young women in Brazil [article in Spanish]. Actas Urol Esp 2013; 37: 156–161.

16.

Zimmern

Litman

Nager

, et al. Effect of aging on storage and voiding function in women with stress predominant urinary incontinence. J Urol 2014; 192: 464–468.

17.

Abelha-Aleixo

Moura

Bernardo

Almeida

Brito

. Lupus cystitis and repercussions of delayed diagnosis. Acta Reumatol Port 2015; 40: 294–298.

18.

Keller

Chen

Lin

. Comorbidities of bladder pain syndrome/interstitial cystitis: A population-based study. BJU Int 2012; 110(11 Pt C): E903–E909.

19.

Nagata

Umeda

Taniguchi

Inada

Kokura

. A case of lupus cystitis complicated by membranous lupus nephritis [article in Japanese]. Nihon Naika Gakkai Zasshi 1990; 79: 820–821.

20.

Zhang

Huang

. Clinical features of lupus cystitis complicated with hydroureteronephrosis in a Chinese population. J Rheumatol 2011; 38: 667–671.

21.

Kurien

Dsouza

Igoe

, et al. Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren’s syndrome model among multiple strains of inbred mice. Clin Exp Immunol 2013; 173: 67–75.

22.

Wang

Jackson

Maughan

, et al. Passive transfer of Sjogren’s syndrome IgG produces the pathophysiology of overactive bladder. Arthritis Rheum 2004; 50: 3637–3645.